Vanda Pharmaceuticals Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vanda Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Vanda Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$4.52M, a 397% decline year-over-year.
  • Vanda Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.9M, a 173% decline year-over-year.
  • Vanda Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $2.51M, a 60% decline from 2022.
  • Vanda Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $6.28M, a 81.1% decline from 2021.
  • Vanda Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $33.2M, a 42.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.51M -$3.77M -60% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-08
2022 $6.28M -$26.9M -81.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-08
2021 $33.2M +$9.82M +42.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 $23.3M -$92.2M -79.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $116M +$90.3M +358% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $25.2M +$40.8M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 -$15.6M +$2.44M +13.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$18M +$21.9M +54.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
2015 -$39.9M -$60.1M -297% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-15
2014 $20.2M +$41.2M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$21.1M +$7.56M +26.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$28.6M -$18.8M -192% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-13
2011 -$9.8M -$17M -236% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $7.19M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.